Byonyks’ X1 APD Cycler Received FDA 510(k) Approval Last Summer

The company is working on its U.S. infrastructure and planning to start U.S. patients soon.

Read the full article » | Posted 02-17-2026

Related Articles

• Xeltis is Trialing its Polymer-based Vascular Access Posted 03-12-2026
• New Bluetooth-enabled CAPD System Enhanced Patient Satisfaction Posted 03-12-2026
• Emerging Biomarker Research in PD Posted 03-12-2026
• FDA granted 510(k) approval to Outset for Next generation Tablo with Cybersecurity Posted 02-17-2026